Cornea

Michael Goldstein, MD, discusses 12-month safety and efficacy trial data of human corneal endothelial cell therapy, presented at the 2024 ESCRS Congress

Phase 1 multicentre study data demonstrate early signs of efficacy

Akantior, an anti-amoebic polymer eye drop, is the first and only authorised medical product for the treatment of AK in the world, according to a news release.

European patients navigate new therapies and market change-ups

Specular microscopy showed "long-term alterations" in corneal cells

The positive opinion comes with the recommendation that ciclosporin 0.1% be granted marketing authorisation in the European Union

Investigators conducted a case-control study to investigate the corneal topography parameters and biomechanics in patients with alopecia areata

Educational resources include handouts, videos and a dedicated webpage on the proper way to use eye drops

The adaptor was tested by low-vision patients and participants with simulated visual impairment

The NP-1/NP-1C preloaded IOL injector has already been made available in parts of Asia

Plasma emission can act as a therapeutic for blepharitis, dry eye and other ocular disease

The flagship, light-based technology has received approval for applications in the anterior and posterior segments

Challenging choices force ophthalmologists to weigh long-term outcomes

Inhibiting ferroptosis could be crucial to reducing inflammation

Astigmatic values differed between K and TK readings

Dr Richard Lindstrom speaks about the future of dry eye and shares pearls for young eye surgeons

Ahead of the ASCRS 2024 meeting, TheiaNova CEO Carissa Fonseca, PhD, pitched a novel keratoconus treatment

Adam Muzychuk, MD, BSc, FRCSC, discusses his ASCRS 2024 presentation on toric lens use for patients with low astigmatism

Greg Kunst, CEO of Aurion Biotech, discusses AURN001, a novel cell therapy targeting corneal endothelial disease

At ASCRS2024, George O. Waring IV, MD, FACS, provides an overview of his presentation highlighting outcomes for LASIK performed using an updated laser ablation algorithm

Laser blended vision is a proven modality for presbyopia treatment, but its principles can be reproduced with EDOF IOLs

Clara Chan, MD, shares surgical pearls for neurotrophic keratopathy and explores new pathways through neurotisation

Penetrating keratoplasty remains a popular choice for certain patients

The company, headquarted in New York and London, named OK-101 as the first IND clearance granted by the FDA for a drug to begin clinical studies specifically to treat NCP

Postoperative outcomes of the tissues obtained from these donors were satisfactory

Why “acceleration” is the industry keyword for 2024

Restoration and regeneration represent a new paradigm

The carbomer-containing eye gels carry risk of microbial contamination, the regulatory agency warned

At this year's American Academy of Ophthalmology meeting in San Francisco, California, Rob Thornhill, CEO of Centricity Vision, spoke with the Ophthalmology Times team about developments in the company's ZEPTOLink IOL positioning systems.

Larger 0.6-mm temporary plug features a tapered edge